DrugPatentWatch Database Preview
Investigational Drug Information for CORT118335
Email this page to a colleague
What is the development status for investigational drug CORT118335?
CORT118335 is an investigational drug.
There have been 9 clinical trials for CORT118335.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 4th 2020.
The most common disease conditions in clinical trials are Weight Gain, Non-alcoholic Fatty Liver Disease, and Fatty Liver. The leading clinical trial sponsors are Corcept Therapeutics, National Institute on Alcohol Abuse and Alcoholism (NIAAA), and The Scripps Research Institute.
There are five US patents protecting this investigational drug and fifty-seven international patents.
Summary for CORT118335
| US Patents | 5 |
| International Patents | 57 |
| US Patent Applications | 25 |
| WIPO Patent Applications | 13 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2020-11-04) |
| Vendors | 3 |
Recent Clinical Trials for CORT118335
| Title | Sponsor | Phase |
|---|---|---|
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | Corcept Therapeutics | Phase 1 |
| Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 2 |
| Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo | The Scripps Research Institute | Phase 2 |
Clinical Trial Summary for CORT118335
Top disease conditions for CORT118335
Top clinical trial sponsors for CORT118335
US Patents for CORT118335
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CORT118335 | ⤷ Try it Free | Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome | Corcept Therapeutics, Inc. (Menlo Park, CA) | ⤷ Try it Free |
| CORT118335 | ⤷ Try it Free | Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists | Corcept Therapeutics, Inc. (Menlo Park, CA) | ⤷ Try it Free |
| CORT118335 | ⤷ Try it Free | Pyrimidine cyclohexyl glucocorticoid receptor modulators | Corcept Therapeutics, Inc. (Menlo Park, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CORT118335
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CORT118335 | Australia | AU2017210156 | 2036-01-19 | ⤷ Try it Free |
| CORT118335 | Canada | CA3011728 | 2036-01-19 | ⤷ Try it Free |
| CORT118335 | European Patent Office | EP3405101 | 2036-01-19 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
